FRA, 38I End of Day and Historical Stock Data []

The worlds #1 website for end of day & historical stock data

wide range of exchanges, data formats, tools and services

APINEW HISTORICAL DATA SYMBOL LISTS MEMBERSHIP REGISTER LOG IN

FRA, 38I: Intellia Therapeutics Inc

04 Sep 2025

LAST: 9.726	CHANGE: 0.27	OPEN: 9.686	HIGH: 10.650	ASK: 0.000	VOLUME: 549
LAST: 9.726	CHG(%): 2.72	PREV: 9.998	LOW: 9.686	BID: 0.000

CHART

Period:

RECENT END OF DAY PRICES

Date	Open	High	Low	Close	Volume
04 Sep 25	9.686	10.650	9.686	9.726	549
03 Sep 25	9.360	10.285	9.360	9.998	1.2K
02 Sep 25	9.554	10.280	9.086	9.928	452
01 Sep 25	9.384	9.384	9.384	9.384	3K
29 Aug 25	9.586	10.510	9.522	9.600	3K
28 Aug 25	9.430	10.000	9.430	10.000	100
27 Aug 25	9.400	9.400	9.400	9.400	200
26 Aug 25	9.358	9.730	9.358	9.730	200
25 Aug 25	8.884	8.884	8.884	8.884	225
22 Aug 25	8.362	8.362	8.362	8.362	225

COMPANY PROFILE

Name:	Intellia Therapeutics Inc
About:	Intellia Therapeutics, Inc., a clinical-stage gene editing company, focuses on the development of curative genome editing treatments. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 that is in Phase 1/2 study for the treatment of hereditary angioedema. It also focusses on the research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. The company has license and collaboration agreement with AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of various of B cell-mediated autoimmune diseases; ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer; and ReCode Therapeutics, Inc. to develop novel genomic medicines for the treatment of cystic fibrosis. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Sector:	Healthcare
Industry:	Biotechnology
Address:	40 Erie Street, Cambridge, MA, United States, 02139
Website:	https://www.intelliatx.com
ISIN:	US45826J1051
LEI:	5493002T5BCPE5DZC723

SYMBOL HISTORY

Purchase End of Day History
for this symbol from Jan 01, 0001

Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

Exchange:

Format:

Period:

Zip file

Symbol:

Start Date:

End Date:

TECHNICAL INDICATORS

MA5:	9.73
MA10:	9.50
MA20:	9.43
MA50:	9.79
MA100:	8.56
MA200:	9.35
STO9:	47.68
STO14:	59.62
RSI14:	53.16
WPR14:	-16.73
MTM14:	0.22
ROC14:	0.02
ATR:	0.67
Week High:	10.65
Week Low:	9.09
Month High:	10.65
Month Low:	8.27
Year High:	20.29
Year Low:	5.34